Enhanced recovery of the nigrostriatal dopaminergic system in MPTP-treated mice following intrastriatal injection of basic fibroblast growth factor in relation to aging.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Brain Research

• Publication date

  1993-09-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-8993(93)90312-BPMID 8106113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast (heparin-binding) growing factors in neuronal development and repair

  2008cited by this paper
• Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

  1992cited by this paper
• Development of human neural transplantation.

  1992cited by this paper
• Putative chromaffin cell survival and enhanced host‐derived TH‐Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease

  1991cited by this paper
• Development of Human Neural Transplantation

  1991cited by this paper
• The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft.

  1991cited by this paper
• Stereotaxic injection of GD1a ganglioside induces limited recovery of striatal dopaminergic system in MPTP‐treated aging mice

  1991cited by this paper
• Development of human neural transplantation. Comments

  1991cited by this paper
• Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.

  1990cited by this paper
• Basic Fibroblast Growth Factor (bFGF) Immunoreactivity Is Present in Chromaffin Granules

  1990cited by this paper
• Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice.

  1990cited by this paper
• Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice

  1990cited by this paper
• Limited recovery of striatal dopaminergic fibers by adrenal medullary grafts in MPTP-treated aging mice.

  1990cited by this paper
• Exogenous GM1 gangliosides induce partial recovery of the nigrostriatal dopaminergic system in MPTP-treated young mice but not in aging mice.

  1989cited by this paper
• The heparin-binding (fibroblast) growth factor family of proteins.

  1989cited by this paper
• Basic Fibroblast Growth Factor in the Adrenal Gland

  1989cited by this paper
• Adrenal medullary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients.

  1989cited by this paper
• Transplantation into the human brain: present status and future possibilities.

  1989cited by this paper
• Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo

  1988cited by this paper
• Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration.

  1988cited by this paper
• VII. The biotransformation of MPTP and disposition of MPP+: Tge effects of aging

  1987cited by this paper
• Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers.

  1987cited by this paper
• Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.

  1987cited by this paper
• Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice.

  1987cited by this paper
• The biotransformation of MPTP and disposition of MPP+: the effects of aging.

  1987cited by this paper
• Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.

  1986cited by this paper
• Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).

  1985cited by this paper
• Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.

  1985cited by this paper
• Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

  1984cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behaviour

  1981cited by this paper

• The role of fibroblast growth factor 2 in drug addiction

  2018cites this paper
• Study of the pair Netrin-1/DCC in Parkinson's diseas

  2018cites this paper
• Reduced ability of calcitriol to promote augmented dopamine release in the lesioned striatum of aged rats

  2017cites this paper
• Role of Neurotrophic Factors in Parkinson's Disease.

  2017cites this paper
• Protection of cultured dopamine neurons from MPP+ requires a combination of neurotrophic factors

  2016influential citation
• A nuclear odyssey: fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system

  2015cites this paper
• Gelatin nanostructured lipid carriers-mediated intranasal delivery of basic fibroblast growth factor enhances functional recovery in hemiparkinsonian rats.

  2014cites this paper
• Bases farmacológicas y moleculares de las disquinesias inducidas por L-dopa en un modelo experimental de la enfermedad de Parkinson

  2014cites this paper
• Neurotoxin-Induced Pathway Perturbation in Human Neuroblastoma SH-EP Cells

  2014cites this paper
• PEGylated rhFGF-2 Conveys Long-term Neuroprotection and Improves Neuronal Function in a Rat Model of Parkinson’s Disease

  2014cites this paper
• Alternative therapies for Morbus Parkinson: Effects of tactile stimulation in a rodent model of Parkinsons disease and induced pluripotent stem cells as a new source for neurotransplantation - therapy

  2014cites this paper
• Cell Fate Analysis of Embryonic Ventral Mesencephalic Grafts in the 6-OHDA Model of Parkinson's Disease

  2012cites this paper
• Role of the prolyl isomerase Pin1 in the pathogenesis of Parkinson's disease and neuroprotection by novel targeted compounds in pre-clinical animal models of the disease

  2012cites this paper
• Degeneration of Axotomized Projection Neurons in the Rat dLGN: Temporal Progression of Events and Their Mitigation by a Single Administration of FGF2

  2012cites this paper
• Unilateral 6-OHDA th-fgfr1(tk-) mouse model supports the role of FGFs in Parkinson's disease and the effects of nicotine and L-DOPA on spontaneous motor impairments

  2012cites this paper
• CDNF Protects the Nigrostriatal Dopamine System and Promotes Recovery after MPTP Treatment in Mice

  2012cites this paper
• Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease

  2012cites this paper
• shRNA Silencing of Endogenous FGF2 in Rat Hippocampus Increases Anxiety Behavior

  2011cites this paper
• Short-hairpin RNA silencing of endogenous fibroblast growth factor 2 in rat hippocampus increases anxiety behavior.

  2011cites this paper
• Use of growth factors for the treatment of Parkinson’s disease

  2010cites this paper
• Glutamate Controls Growth Rate and Branching of Dopaminergic Axons

  2009cites this paper
• Simvastatin Inhibits the Activation of p21ras and Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease

  2009cites this paper
• Neurotrophic support of midbrain dopaminergic neurons.

  2009cites this paper
• On dopamine neurons : nerve fiber outgrowth and L-DOPA effects

  2008cites this paper
• Neurotrophic Factors in Neurodegenerative Disorders

  2008cites this paper
• Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

  2008cites this paper
• Dopamine neurons in ventral mesencephalon - Interactions with glia and locus coeruleus

  2008cites this paper
• Fibroblast Growth Factor (FGF)-2 and FGF Receptor 3 Are Required for the Development of the Substantia Nigra, and FGF-2 Plays a Crucial Role for the Rescue of Dopaminergic Neurons after 6-Hydroxydopamine Lesion

  2007influential citation
• Myelin basic protein-primed T cells induce neurotrophins in glial cells via alphavbeta3 [corrected] integrin.

  2007cites this paper
• Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via α5β3 Integrin*

  2007cites this paper
• The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system.

  2007cites this paper
• Nucleofection Is the Most Efficient Nonviral Transfection Method for Neuronal Stem Cells Derived from Ventral Mesencephali with No Changes in Cell Composition or Dopaminergic Fate

  2006cites this paper
• FGF‐2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice

  2006cites this paper
• New Therapeutic Approaches to Parkinson’s Disease Including Neural Transplants

  2005cites this paper
• An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.

  2005cites this paper
• Toxicity of semaphorin3A for dopaminergic neurons.

  2005cites this paper
• Influences of dopaminergic lesion on epidermal growth factor‐ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons

  2005cites this paper
• Neurorescue effects of VEGF on a rat model of Parkinson's disease.

  2005cites this paper
• Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms.

  2004cites this paper
• Immunophilin Ligands and Dopamine Neurons

  2003cites this paper
• Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease

  2001cites this paper
• Delivery of Neurotrophic Factors to the Central Nervous System

  2001cites this paper
• Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases.

  2000cites this paper
• Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism

  2000cites this paper
• Central nicotinic receptors, neurotrophic factors and neuroprotection.

  2000cites this paper
• Golf ball epilepsy

  2000cites this paper
• Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long-lasting sensitization to stimulant drugs: studies in the rat

  2000cites this paper
• Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine.

  2000cites this paper
• Neurotrophic effects of central nicotinic receptor activation.

  2000cites this paper
• Diazepam induces FGF-2 mRNA in the hippocampus and striatum.

  2000cites this paper
• The high molecular weight fibroblast growth factor-2 isoforms (21,000 mol. wt and 23,000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro.

  2000cites this paper
• Neural Transplantation for Parkinson's Disease

  1999cites this paper
• Trophic Factors in Experimental Models of Adult Central Nervous System Injury

  1999cites this paper
• A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.

  1998cites this paper
• Immunohistochemical analyses of fibroblast growth factor receptor-1 in the human substantia nigra. Comparison between normal and Parkinson's disease cases.

  1998cites this paper
• [Neural transplantation and regeneration: current status and future perspective].

  1998cites this paper
• L1 neural cell adhesion molecule is a survival factor for fetal dopaminergic neurons

  1998cites this paper
• Blockade of Basic Fibroblast Growth Factor Retards Recovery from Motor Cortex Injury in Rats

  1997cites this paper
• Long-term enhanced chromaffin cell survival and behavioral recovery in hemiparkinsonian rats with co-grafted polymer-encapsulated human NGF-secreting cells.

  1997cites this paper
• Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat

  1997cites this paper
• Early Detection of Parkinson’s Disease

  1996cites this paper
• Early effects of basic fibroblast growth factor on foetal rat mesencephalic cell suspensions.

  1996cites this paper
• Cografting with polymer-encapsulated human nerve growth factor-secreting cells and chromaffin cell survival and behavioral recovery in hemiparkinsonian rats.

  1996cites this paper
• Parkinson's disease, trophic factors, and adrenal medullary chromaffin cell grafting: basic and clinical studies.

  1996cites this paper
• Neurotrophin-4/5 selectively protects nigral calbindin-containing neurons in rats with medial forebrain bundle transections.

  1996cites this paper
• Chromaffin cell survival from both young and old donors is enhanced by co-grafts of polymer-encapsulated human NGF-secreting cells.

  1996cites this paper
• Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting.

  1996cites this paper
• Basic fibroblast growth factor in the injured brain

  1995cites this paper
• Inhibitors of Type IV Phosphodiesterases Reduce the Toxicity of MPTP in Substantia Nigra Neurons In Vivo

  1995cites this paper
• Neurotrophic factors: repair and regeneration in the central nervous system

  1995cites this paper
• Chromaffin cell survival prolonged by nerve growth factor from pretransected sciatic nerve.

  1995cites this paper
• Neuronal transplantation and neurotrophic factors in the treatment of Parkinson's disease--update February 1995.

  1995cites this paper
• Chromaffin Cell Survival Prolonged by Nerve Growth Factor from Pretransected Sciatic Nerve

  1995cites this paper
• Cografts of Adrenal Medulla with Peripheral Nerve for Parkinson's Disease

  1994cites this paper
• Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease.

  1994cites this paper